As the World Health Assembly (WHA) approaches in late May, WHO members will discuss a proposed resolution on transparency. The U.S. Congress is also considering a number bills that would require greater transparency, and groups like KEI have asked the… Continue Reading
On October 3, 2023, Knowledge Ecology International (KEI) sent a letter to the FDA asking the agency to publish its historical Orange Book data. The Orange Book identifies patent and exclusivity data for FDA approved drug products. The FDA publicly… Continue Reading
The PDF version of the letter has all tables and footnotes: KEI-NIH-28Aug2028 August 28, 2024 Abby Rives, JD Division Director Technology Transfer and Innovation Policy National Institutes for Health Vladimir Knezevic, MD Senior Advisor for Commercial Evaluation Technology Advancement Office… Continue Reading
On July 17, 2024, Knowledge Ecology International (KEI) joined Universities Allied for Essential Medicines, Dr. Christopher Morten, and Dr. Reshma Ramachandran in submitting an amicus brief in the case of the Center for Investigative Reporting, et al. v. United States… Continue Reading
On Tuesday, 28 May 2024, Knowledge Ecology International (KEI) delivered this constituency statement on behalf of KEI, Health Action International, Oxfam, World Blind Union, and the World Council of Churches on the following topic: Intergovernmental Negotiating Body to draft and… Continue Reading
On 17 April 2024, the World Health Organization (WHO) published the Proposed Bureau’s text in advance of the 8th meeting of the Working Group on Amendments to the International Health Regulations (2005) (WGIHR) which meets from 22–26 April 2024. Accompanying… Continue Reading
INB 9 Written statement by Knowledge Ecology International 28 March 2024 Transparency The negotiations on a WHO pandemic agreement should be more transparent. The negotiating texts with attributed country positions should be public and the meetings should be webcast. These… Continue Reading
On Wednesday, 24 January 2024, Knowledge Ecology International (KEI) delivered the following statement on the Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. The innovation for… Continue Reading
KEI statement to the Working Group on Amendments to the International Health Regulations December 7, 2023 KEI agrees with others that the IHR regulations should incorporate measures to address equitable access to products. KEI reminds delegations that in 2019, the… Continue Reading
In May 2023, the World Health Organization (WHO) published the global vaccine market report. Underpinning this technical report on vaccine market dynamics was a strong push by WHO’s Director-General, Tedros Adhanom Ghebreyesus, for increased transparency and equity; transparency is mentioned… Continue Reading